Research
-
VUMC begins study of second COVID-19 vaccine
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read MoreNov 2, 2020
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
Vanderbilt trans-institutional team shows how next-gen wearable sensor algorithms powered by machine learning could be key to preventing injuries that sideline runners
An interdisciplinary team of researchers led by Karl Zelik explores how wearable sensor technology can monitor bone stress in runners, developing a new multi-sensor algorithm that could save runners from months of pain and recovery time. Read MoreOct 28, 2020
-
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read MoreOct 27, 2020
-
Team examines operating limits in solid-state batteries to improve driving range of electric vehicles
There is huge momentum toward adoption of battery electric vehicles primarily because performances are meeting or exceeding the properties of traditional automobiles. Consumers want electric vehicles that have similar driving range (energy density) and charging styles and times (power density) to gasoline powered vehicles. “One pathway to improving the energy density of the battery, or... Read MoreOct 22, 2020
-
Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth
Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read MoreOct 15, 2020
-
Possible COVID-19 “decoy”
It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read MoreOct 15, 2020
-
AI-based tech to improve stroke outcomes
Two prototype devices could refine thrombectomy through sensory augmentation. Read MoreOct 14, 2020
-
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. Read MoreOct 13, 2020
-
Study shows that repeated statements are more often judged to be true, regardless of a person’s age or prior knowledge
Researchers from Vanderbilt Peabody College of education and human development ask two questions in a recent study related to the illusory-truth effect: Do adults learn during childhood to associate repetition as a cue for truth, and can their prior knowledge protect them from the effect? Read MoreOct 6, 2020
-
Vanderbilt’s Humphreys receives Brain and Behavior Research Foundation Young Investigator Grant
Kathryn Humphreys, assistant professor of psychology and human development at Vanderbilt Peabody College of education and human development, was awarded a Young Investigator Grant from the Brain and Behavior Research Foundation in an announcement made September 21. Read MoreOct 6, 2020
-
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses
All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read MoreOct 6, 2020
-
Nominations sought for 2021 Vanderbilt Prize in Biomedical Science
Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11. Read MoreOct 5, 2020
-
Team’s sustained work in T-cell immune response awarded P01 grant totaling $11 million
For more than a decade Matt Lang and collaborators across the U.S. have worked to recreate key components of T-cells and how they know when to start fighting disease. Conventional wisdom suggested that T-cells formed regular, force-free bonds with infected cells, and in doing so caused the chain reaction of immune response. The team slowly... Read MoreOct 4, 2020
-
$8.7 million DARPA grant advances AI-assisted CPS design work
A new, $8.7 million project—Design. R–AI-assisted CPS Design—involves pathbreaking work for the Defense Advanced Research Projects Agency as future cyber-physical systems will rely less on human control and more machine learning algorithms and artificial intelligence processors. Read MoreOct 4, 2020
-
Recent books by Peabody faculty
Books on specific strategies and practices for using digital tools to reduce inequities in educational opportunities and improve student outcomes and the core ingredients of leadership have been recently published by Vanderbilt faculty. Read MoreOct 2, 2020
-
NSF seed grant supports biomanufacturing of new drug delivery technologies
Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no side effects. The ability to engineer the... Read MoreOct 2, 2020
-
Vanderbilt and Australian researchers collaborate to solve decades-long debate about decision-making
Psychology researchers develop new methodologies and representations of how people react to incoming information to better understand complex decision-making. Read MoreOct 1, 2020
-
Vanderbilt biologists test evolutionary theories with novel empirical study of ‘cheater’ mitochondria
Studying “cheater” and “cooperative” mitochondria under environmental pressure delivers solid evolutionary conclusions in a longstanding theoretical field. Read MoreSep 25, 2020
-
Study identifies antibodies that block alphaviruses
Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern. Read MoreSep 20, 2020